- All sections
- C - Chemistry; metallurgy
- C07J - Steroids
- C07J 63/00 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
Patent holdings for IPC class C07J 63/00
Total number of patents in this class: 487
10-year publication summary
29
|
26
|
53
|
36
|
33
|
43
|
32
|
35
|
33
|
7
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Reata Pharmaceuticals, Inc. | 127 |
37 |
Reata Pharmaceuticals Holdings, LLC | 42 |
18 |
Sage Therapeutics, Inc. | 312 |
15 |
ViiV Healthcare UK (no.5) Limited | 86 |
13 |
Hetero Labs Limited | 46 |
13 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 762 |
12 |
Bristol-myers Squibb Company | 5080 |
9 |
Glaxosmithkline LLC | 566 |
7 |
Ardelyx, Inc. | 109 |
7 |
Pacific Arrow Limited | 19 |
7 |
Glaxosmithkline Biologicals S.A. | 1701 |
6 |
Adjuvance Technologies, Inc., AKA Adjuvance | 21 |
6 |
Daiichi Sankyo Company, Limited | 1829 |
6 |
Regents of the University of Minnesota | 2620 |
6 |
ViiV Healthcare UK (No. 4) Limited | 25 |
6 |
ViiV Healthcare UK (No. 5) Limited | 42 |
6 |
Glaxosmithkline Intellectual Property (no.2) Limited | 269 |
5 |
Memorial Sloan-Kettering Cancer Center | 1789 |
5 |
Valtion Teknillinen Tutkimuskeskus | 183 |
5 |
The General Hospital Corporation | 4517 |
4 |
Other owners | 294 |